\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\:\\ blood\\ pressure\\ 122\\/64\\,\\ pulse\\ 84\\,\\ respiratory\\ rate\\ 12\\,\\ temperature\\ 36\\.8\\,\\ oxygen\\ saturation\\ 92\\%\\ on\\ room\\ air\\.\\ \\ patient\\ is\\ an\\ obese\\ female\\ in\\ no\\ acute\\ distress\\.\\ \\ alert\\ and\\ oriented\\ to\\ person\\,\\ time\\,\\ and\\ place\\.\\ \\ extraoccular\\ movements\\ intact\\.\\ \\ pupils\\ equal\\ and\\ reactive\\ to\\ light\\.\\ moist\\ mucous\\ membranes\\ with\\ clear\\ oropharynx\\.\\ \\ neck\\ supple\\ without\\ thyromegaly\\.\\ \\ regular\\ heart\\ rate\\ and\\ rhythm\\.\\ normal\\ s1\\ and\\ s2\\ without\\ appreciable\\ murmur\\,\\ rub\\ or\\ gallop\\.\\ no\\ jvd\\.\\ \\ diminished\\ breath\\ sounds\\ bilaterally\\.\\ no\\ wheezes\\,\\ rales\\,\\ or\\ rhonchi\\.\\ normal\\ bowel\\ sounds\\.\\ \\ soft\\ nontender\\,\\ nondistended\\.\\ \\ 1\\+\\ pitting\\ edema\\ in\\ bilateral\\ lower\\ extremities\\.\\ no\\ clubbing\\ or\\ cyanosis\\.\\ \\ neuro\\ exam\\ grossly\\ normal\\.\ \(0\)\
\-\ labs\\:\\ sodium\\ 139\\,\\ potassium\\ 4\\.8\\,\\ chloride\\ 101\\,\\ bicarbonate\\ 29\\,\\ bun\\ 6\\,\\ creatinine\\ 0\\.7\\,\\ glucose\\ 92\\,\\ calcium\\ 9\\.5\\.\\ hemoglobin\\ 14\\.4\\,\\ hematocrit\\ 41\\.2\\,\\ wbc\\ 7\\.8\\,\\ platelets\\ 241\\,000\\.\\ \\ ekg\\:\\ nsr\\.\ \(0\)\
\-\ treatment\\:\\ most\\ patients\\ are\\ treated\\ symptomatically\\.\\ \\ recurrent\\ pneumothoraces\\ are\\ treated\\ with\\ pleural\\ abrasion\\,\\ pleurodesis\\,\\ or\\ pleurectomy\\.\\ \\ chylous\\ effusion\\ can\\ be\\ managed\\ with\\ thoracentesis\\,\\ chemical\\ pleurodesis\\,\\ or\\ partial\\ pleurectomy\\.\\ antiestrogen\\ measures\\ have\\ also\\ been\\ employed\\:\\ surgical\\ oophorectomy\\,\\ ovarian\\ irradiation\\,\\ hormonal\\ therapy\\ \\(tamoxifen\\,\\ gonadotrophin\\ releasing\\ hormone\\ agonist\\,\\ luteinizing\\ hormone\\ releasing\\ hormone\\,\\ and\\ progesterone\\ administration\\)\\.\\ \\ lung\\ transplantation\\ may\\ be\\ performed\\ in\\ end\\-stage\\ disease\\.\ \(0\)\
\-\ follow\\-up\\:\\ lung\\ function\\ decline\\ in\\ lam\\ patients\\ is\\ measured\\ with\\ fev\\-1\\.\\ \\ cardiopulmonary\\ exercise\\ testing\\ is\\ using\\ to\\ determine\\ supplemental\\ oxygen\\ requirements\\ and\\ may\\ provide\\ helpful\\ referral\\ parameters\\ for\\ lung\\ transplantation\\.\ \(0\)\
\-\ \\â\\€\\¢\\ cxr\\:\\ lungs\\ clear\\.\\ \\ cardiomegaly\\.\ \(0\)\
\-\ \\â\\€\\¢\\ ct\\ chest\\:\\ multiple\\ bilateral\\ and\\ diffuse\\ thin\\-walled\\ cysts\\ relatively\\ homogeneous\\ in\\ size\\.\ \(0\)\
\-\ lymphangioleiomyomatosis\ \(13\)\
\-\ \\â\\€\\¢\\ langerhans\\ cell\\ histiocytosis\\ \\(eosinophilic\\ granuloma\\)\ \(0\)\
\-\ \\â\\€\\¢\\ centrilobular\\ emphysema\ \(0\)\
\-\ \\â\\€\\¢\\ lymphocytic\\ interstitial\\ pneumonia\ \(0\)\
\-\ \\â\\€\\¢\\ cystic\\ bronchiectasis\ \(0\)\
\-\ \\â\\€\\¢\\ idiopathic\\ pulmonary\\ fibrosis\ \(0\)\
\-\ 40\\ year\\ old\\ woman\\ with\\ history\\ of\\ hypertension\\,\\ obstructive\\ sleep\\ apnea\\ on\\ cpap\\,\\ and\\ morbid\\ obesity\\.\\ \\ multiple\\ hospitalizations\\ for\\ shortness\\ of\\ breath\\.\ \(0\)\
\-\ lymphangioleiomyomatosis\\ \\(lam\\)\\ is\\ a\\ rare\\ interstitial\\ lung\\ disease\\ that\\ affects\\ only\\ women\\,\\ typically\\ during\\ their\\ reproductive\\ years\\.\\ a\\ small\\ percentage\\ of\\ patients\\,\\ also\\ usually\\ women\\,\\ have\\ lam\\ in\\ association\\ with\\ tuberous\\ sclerosis\\.\\ lam\\ is\\ characterized\\ by\\ the\\ abnormal\\ proliferation\\ of\\ smooth\\ muscle\\ cells\\ in\\ the\\ lungs\\ and\\ in\\ the\\ thoracic\\ and\\ retroperitoneal\\ lymphatics\\.\\ affected\\ patients\\ are\\ also\\ at\\ risk\\ of\\ developing\\ renal\\ hamartomas\\ and\\ angiomyolipomas\\.\\ patients\\ with\\ lam\\ characteristically\\ present\\ with\\ chronic\\ cough\\ and\\ dyspnea\\ and\\ less\\ commonly\\ with\\ spontaneous\\ pneumothorax\\.\\ at\\ radiography\\,\\ lam\\ manifests\\ with\\ normal\\ to\\ increased\\ lung\\ volumes\\ and\\ interstitial\\ reticular\\ opacities\\ that\\ are\\ often\\ subtle\\.\\ unilateral\\ pneumothorax\\ and\\ unilateral\\ or\\ bilateral\\ chylous\\ pleural\\ effusions\\ are\\ frequent\\ radiographic\\ findings\\.\\ computed\\ tomography\\ \\(ct\\)\\ demonstrates\\ bilateral\\ diffuse\\ thin\\-walled\\ cysts\\ surrounded\\ by\\ normal\\ lung\\ parenchyma\\.\\ ct\\ may\\ also\\ demonstrate\\ associated\\ chylous\\ pleural\\ effusions\\ or\\ pneumothorax\\ and\\ thoracic\\ or\\ abdominal\\ lymphadenopathy\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ lam\\:\\ 0\\.34811440944933925\ \(0\)\
\-\ chylous\\:\\ 0\\.20925738077936967\ \(0\)\
\-\ lung\\:\\ 0\\.16659973460620497\ \(0\)\
\-\ and\\:\\ 0\\.16034506092812975\ \(0\)\
\-\ hormone\\:\\ 0\\.1394320385493599\ \(0\)\
\-\ pleurectomy\\:\\ 0\\.1313298325071941\ \(0\)\
\-\ pleurodesis\\:\\ 0\\.12841201729981025\ \(0\)\
\-\ releasing\\:\\ 0\\.12841201729981025\ \(0\)\
\-\ patients\\:\\ 0\\.1283901601370762\ \(0\)\
\-\ or\\:\\ 0\\.12703376604974237\ \(0\)\
\-\ interstitial\\:\\ 0\\.12413914023570674\ \(0\)\
\-\ pneumothorax\\:\\ 0\\.11934292992479173\ \(0\)\
\-\ lymphangioleiomyomatosis\\:\\ 0\\.11374799687973042\ \(0\)\
\-\ transplantation\\:\\ 0\\.10622621086027118\ \(0\)\
\-\ pleural\\:\\ 0\\.10308462301158881\ \(0\)\
\-\ bilateral\\:\\ 0\\.0981260823317732\ \(0\)\
\-\ 92\\:\\ 0\\.09689372637828664\ \(0\)\
\-\ oxygen\\:\\ 0\\.09385233004357402\ \(0\)\
\-\ normal\\:\\ 0\\.09318354717702282\ \(0\)\
\-\ in\\:\\ 0\\.09084074667927407\ \(0\)\
\-\ with\\:\\ 0\\.08937939338964156\ \(0\)\
\-\ are\\:\\ 0\\.08660176066552652\ \(0\)\
\-\ also\\:\\ 0\\.08588114589683096\ \(0\)\
\-\ effusions\\:\\ 0\\.08543290634678068\ \(0\)\
\-\ unilateral\\:\\ 0\\.08354794475116191\ \(0\)\
\-\ women\\:\\ 0\\.08215544282511336\ \(0\)\
\-\ antiestrogen\\:\\ 0\\.07299692646363695\ \(0\)\
\-\ gonadotrophin\\:\\ 0\\.07299692646363695\ \(0\)\
\-\ agonist\\:\\ 0\\.07299692646363695\ \(0\)\
\-\ sounds\\:\\ 0\\.07048052359426718\ \(0\)\
\-\ extraoccular\\:\\ 0\\.06975246025978989\ \(0\)\
\-\ luteinizing\\:\\ 0\\.06975246025978989\ \(0\)\
\-\ rate\\:\\ 0\\.06917757800972507\ \(0\)\
\-\ cysts\\:\\ 0\\.06917757800972507\ \(0\)\
\-\ may\\:\\ 0\\.06891060884350411\ \(0\)\
\-\ thoracic\\:\\ 0\\.06821898753105345\ \(0\)\
\-\ lungs\\:\\ 0\\.06737331355557115\ \(0\)\
\-\ breath\\:\\ 0\\.06690940639395689\ \(0\)\
\-\ clear\\:\\ 0\\.06618311145139448\ \(0\)\
\-\ nsr\\:\\ 0\\.06566491625359705\ \(0\)\
\-\ requirements\\:\\ 0\\.06566491625359705\ \(0\)\
\-\ symptomatically\\:\\ 0\\.06420600864990512\ \(0\)\
\-\ morbid\\:\\ 0\\.06420600864990512\ \(0\)\
\-\ bicarbonate\\:\\ 0\\.06297251984655741\ \(0\)\
\-\ is\\:\\ 0\\.06250151010015044\ \(0\)\
\-\ abrasion\\:\\ 0\\.06190402324386743\ \(0\)\
\-\ lymphatics\\:\\ 0\\.06190402324386743\ \(0\)\
\-\ rub\\:\\ 0\\.060961542446058045\ \(0\)\
\-\ gallop\\:\\ 0\\.060961542446058045\ \(0\)\
\-\ hospitalizations\\:\\ 0\\.060961542446058045\ \(0\)\
\-\ reproductive\\:\\ 0\\.060961542446058045\ \(0\)\
\-\ pitting\\:\\ 0\\.06011846464371228\ \(0\)\
\-\ pneumothoraces\\:\\ 0\\.06011846464371228\ \(0\)\
\-\ thoracentesis\\:\\ 0\\.06011846464371228\ \(0\)\
\-\ tamoxifen\\:\\ 0\\.06011846464371228\ \(0\)\
\-\ no\\:\\ 0\\.05937345456960022\ \(0\)\
\-\ progesterone\\:\\ 0\\.05935580800304463\ \(0\)\
\-\ cpap\\:\\ 0\\.05935580800304463\ \(0\)\
\-\ thyromegaly\\:\\ 0\\.058659557040020356\ \(0\)\
\-\ supplemental\\:\\ 0\\.058659557040020356\ \(0\)\
\-\ centrilobular\\:\\ 0\\.058659557040020356\ \(0\)\
\-\ parameters\\:\\ 0\\.05801906824155654\ \(0\)\
\-\ chloride\\:\\ 0\\.057426068236672644\ \(0\)\
\-\ oophorectomy\\:\\ 0\\.057426068236672644\ \(0\)\
\-\ diffuse\\:\\ 0\\.0572506271691177\ \(0\)\
\-\ manifests\\:\\ 0\\.05687399843986521\ \(0\)\
\-\ treated\\:\\ 0\\.05684935678595245\ \(0\)\
\-\ 139\\:\\ 0\\.05635757163398267\ \(0\)\
\-\ irradiation\\:\\ 0\\.05635757163398267\ \(0\)\
\-\ hormonal\\:\\ 0\\.05635757163398267\ \(0\)\
\-\ hamartomas\\:\\ 0\\.05635757163398267\ \(0\)\
\-\ angiomyolipomas\\:\\ 0\\.05635757163398267\ \(0\)\
\-\ potassium\\:\\ 0\\.05541509083617328\ \(0\)\
\-\ apnea\\:\\ 0\\.054982453677908764\ \(0\)\
\-\ percentage\\:\\ 0\\.054982453677908764\ \(0\)\
\-\ employed\\:\\ 0\\.05457201303382752\ \(0\)\
\-\ characteristically\\:\\ 0\\.05457201303382752\ \(0\)\
\-\ jvd\\:\\ 0\\.05418160203282557\ \(0\)\
\-\ appreciable\\:\\ 0\\.053453660579935836\ \(0\)\
\-\ cardiopulmonary\\:\\ 0\\.053453660579935836\ \(0\)\
\-\ volumes\\:\\ 0\\.053453660579935836\ \(0\)\
\-\ sodium\\:\\ 0\\.05311310543013559\ \(0\)\
\-\ decline\\:\\ 0\\.05311310543013559\ \(0\)\
\-\ reticular\\:\\ 0\\.05217062463232621\ \(0\)\
\-\ ct\\:\\ 0\\.05213289331556654\ \(0\)\
\-\ nondistended\\:\\ 0\\.05187961662678788\ \(0\)\
\-\ person\\:\\ 0\\.05159882156230681\ \(0\)\
\-\ platelets\\:\\ 0\\.05159882156230681\ \(0\)\
\-\ lymphocytic\\:\\ 0\\.05132754682998045\ \(0\)\
\-\ moist\\:\\ 0\\.05056489018931279\ \(0\)\
\-\ obesity\\:\\ 0\\.05056489018931279\ \(0\)\
\-\ 101\\:\\ 0\\.050094058026632735\ \(0\)\
\-\ oropharynx\\:\\ 0\\.04986863922628852\ \(0\)\
\-\ supple\\:\\ 0\\.04986863922628852\ \(0\)\
\-\ clubbing\\:\\ 0\\.04986863922628852\ \(0\)\
\-\ chemical\\:\\ 0\\.049649397067109434\ \(0\)\
\-\ proliferation\\:\\ 0\\.04902556142394276\ \(0\)\
\-\ ekg\\:\\ 0\\.04882797513246641\ \(0\)\
\-\ rhonchi\\:\\ 0\\.04844686318914332\ \(0\)\
\-\ hemoglobin\\:\\ 0\\.0482629047832751\ \(0\)\
\-\ without\\:\\ 0\\.04815246131615503\ \(0\)\
\-\ wheezes\\:\\ 0\\.04808308062613337\ \(0\)\
\-\ membranes\\:\\ 0\\.04790720897005107\ \(0\)\
\-\ langerhans\\:\\ 0\\.04790720897005107\ \(0\)\
\-\ cardiomegaly\\:\\ 0\\.04773511979488632\ \(0\)\
\-\ bronchiectasis\\:\\ 0\\.04773511979488632\ \(0\)\
\-\ 84\\:\\ 0\\.0474016616195931\ \(0\)\
\-\ saturation\\:\\ 0\\.0474016616195931\ \(0\)\
\-\ cyanosis\\:\\ 0\\.0474016616195931\ \(0\)\
\-\ obese\\:\\ 0\\.04724000282378761\ \(0\)\
\-\ hematocrit\\:\\ 0\\.04724000282378761\ \(0\)\
\-\ mucous\\:\\ 0\\.04708154540359279\ \(0\)\
\-\ surrounded\\:\\ 0\\.04692616502178701\ \(0\)\
\-\ affects\\:\\ 0\\.0467737444470178\ \(0\)\
\-\ referral\\:\\ 0\\.04662417302244145\ \(0\)\
\-\ sleep\\:\\ 0\\.04662417302244145\ \(0\)\
\-\ radiography\\:\\ 0\\.04662417302244145\ \(0\)\
\-\ temperature\\:\\ 0\\.04647734618311996\ \(0\)\
\-\ creatinine\\:\\ 0\\.04647734618311996\ \(0\)\
\-\ provide\\:\\ 0\\.04619153586417693\ \(0\)\
\-\ exam\\:\\ 0\\.04595583112719056\ \(0\)\
\-\ histiocytosis\\:\\ 0\\.04578109522009568\ \(0\)\
\-\ to\\:\\ 0\\.04564503812274305\ \(0\)\
\-\ have\\:\\ 0\\.0456047588146472\ \(0\)\
\-\ tuberous\\:\\ 0\\.045518716362206516\ \(0\)\
\-\ pupils\\:\\ 0\\.04526466841421314\ \(0\)\
\-\ diminished\\:\\ 0\\.04526466841421314\ \(0\)\
\-\ movements\\:\\ 0\\.04501843857942803\ \(0\)\
\-\ measured\\:\\ 0\\.04501843857942803\ \(0\)\
\-\ rales\\:\\ 0\\.044898107917402647\ \(0\)\
\-\ emphysema\\:\\ 0\\.0447795599975551\ \(0\)\
\-\ of\\:\\ 0\\.04466301055665578\ \(0\)\
\-\ managed\\:\\ 0\\.044662742766203994\ \(0\)\
\-\ multiple\\:\\ 0\\.04465231397256806\ \(0\)\
\-\ eosinophilic\\:\\ 0\\.04443410326216079\ \(0\)\
\-\ tomography\\:\\ 0\\.0442118156840174\ \(0\)\
\-\ glucose\\:\\ 0\\.044102945457224665\ \(0\)\
\-\ bun\\:\\ 0\\.04399553661994054\ \(0\)\
\-\ retroperitoneal\\:\\ 0\\.04399553661994054\ \(0\)\
\-\ computed\\:\\ 0\\.04399553661994054\ \(0\)\
\-\ s2\\:\\ 0\\.04388955045813924\ \(0\)\
\-\ grossly\\:\\ 0\\.043784949776080315\ \(0\)\
\-\ equal\\:\\ 0\\.04368169881793994\ \(0\)\
\-\ developing\\:\\ 0\\.04368169881793994\ \(0\)\
\-\ opacities\\:\\ 0\\.043579763194434254\ \(0\)\
\-\ rhythm\\:\\ 0\\.04328152352258165\ \(0\)\
\-\ murmur\\:\\ 0\\.04328152352258165\ \(0\)\
\-\ helpful\\:\\ 0\\.04328152352258165\ \(0\)\
\-\ pulse\\:\\ 0\\.04308869881305604\ \(0\)\
\-\ nontender\\:\\ 0\\.04299400139739996\ \(0\)\
\-\ exercise\\:\\ 0\\.04299400139739996\ \(0\)\
\-\ neuro\\:\\ 0\\.04253662901624861\ \(0\)\
\-\ determine\\:\\ 0\\.04244821001459222\ \(0\)\
\-\ obstructive\\:\\ 0\\.04244821001459222\ \(0\)\
\-\ alert\\:\\ 0\\.04202020221036607\ \(0\)\
\-\ characterized\\:\\ 0\\.041937280864873805\ \(0\)\
\-\ frequent\\:\\ 0\\.04185521000970833\ \(0\)\
\-\ granuloma\\:\\ 0\\.04130314021290089\ \(0\)\
\-\ calcium\\:\\ 0\\.041227292837133035\ \(0\)\
\-\ oriented\\:\\ 0\\.04115215765381209\ \(0\)\
\-\ place\\:\\ 0\\.04115215765381209\ \(0\)\
\-\ association\\:\\ 0\\.04107772141255668\ \(0\)\
\-\ testing\\:\\ 0\\.041003971229365915\ \(0\)\
\-\ homogeneous\\:\\ 0\\.04030160499036031\ \(0\)\
\-\ dyspnea\\:\\ 0\\.04016823793256754\ \(0\)\
\-\ s1\\:\\ 0\\.039844232609208975\ \(0\)\
\-\ 29\\:\\ 0\\.03978097664159724\ \(0\)\
\-\ spontaneous\\:\\ 0\\.03971821680432838\ \(0\)\
\-\ that\\:\\ 0\\.039616780847633516\ \(0\)\
\-\ light\\:\\ 0\\.0395328377436438\ \(0\)\
\-\ regular\\:\\ 0\\.03941159545094445\ \(0\)\
\-\ subtle\\:\\ 0\\.039351656307517885\ \(0\)\
\-\ reactive\\:\\ 0\\.03917448659997161\ \(0\)\
\-\ ovarian\\:\\ 0\\.03888765165227603\ \(0\)\
\-\ by\\:\\ 0\\.03876736556356504\ \(0\)\
\-\ idiopathic\\:\\ 0\\.038610743805861256\ \(0\)\
\-\ disease\\:\\ 0\\.03832063199584287\ \(0\)\
\-\ fibrosis\\:\\ 0\\.03823849816619555\ \(0\)\
\-\ their\\:\\ 0\\.03788280235297151\ \(0\)\
\-\ smooth\\:\\ 0\\.037686428369388125\ \(0\)\
\-\ using\\:\\ 0\\.03754224720317128\ \(0\)\
\-\ affected\\:\\ 0\\.03754224720317128\ \(0\)\
\-\ room\\:\\ 0\\.03735395996937379\ \(0\)\
\-\ measures\\:\\ 0\\.037215596206708064\ \(0\)\
\-\ relatively\\:\\ 0\\.03717000156350558\ \(0\)\
\-\ parenchyma\\:\\ 0\\.03707958435026879\ \(0\)\
\-\ be\\:\\ 0\\.037033025330212556\ \(0\)\
\-\ function\\:\\ 0\\.036945845779221456\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.03690175840470746\ \(0\)\
\-\ distress\\:\\ 0\\.036770935247184756\ \(0\)\
\-\ recurrent\\:\\ 0\\.036599766405361896\ \(0\)\
\-\ shortness\\:\\ 0\\.036599766405361896\ \(0\)\
\-\ cxr\\:\\ 0\\.03651553575147562\ \(0\)\
\-\ administration\\:\\ 0\\.03634968860790003\ \(0\)\
\-\ respiratory\\:\\ 0\\.03630875839982357\ \(0\)\
\-\ pneumonia\\:\\ 0\\.03602796333534251\ \(0\)\
\-\ partial\\:\\ 0\\.03516913387784704\ \(0\)\
\-\ cells\\:\\ 0\\.03516913387784704\ \(0\)\
\-\ hypertension\\:\\ 0\\.03492505017107053\ \(0\)\
\-\ pressure\\:\\ 0\\.03475515338047555\ \(0\)\
\-\ extremities\\:\\ 0\\.03468819200032616\ \(0\)\
\-\ at\\:\\ 0\\.03448168842955624\ \(0\)\
\-\ rare\\:\\ 0\\.03445814384594358\ \(0\)\
\-\ cough\\:\\ 0\\.03407853884014512\ \(0\)\
\-\ effusion\\:\\ 0\\.03389528262709312\ \(0\)\
\-\ radiographic\\:\\ 0\\.03386514384105969\ \(0\)\
\-\ commonly\\:\\ 0\\.03377540265859526\ \(0\)\
\-\ 40\\:\\ 0\\.033569839546434464\ \(0\)\
\-\ intact\\:\\ 0\\.03303712124208665\ \(0\)\
\-\ risk\\:\\ 0\\.03261448370444415\ \(0\)\
\-\ sclerosis\\:\\ 0\\.03251222239916905\ \(0\)\
\-\ muscle\\:\\ 0\\.032411251491829725\ \(0\)\
\-\ wbc\\:\\ 0\\.03226214460170719\ \(0\)\
\-\ typically\\:\\ 0\\.03204356790373121\ \(0\)\
\-\ heart\\:\\ 0\\.0317380274173066\ \(0\)\
\-\ labs\\:\\ 0\\.03162354995362081\ \(0\)\
\-\ 12\\:\\ 0\\.031202886220053485\ \(0\)\
\-\ less\\:\\ 0\\.031053314795477134\ \(0\)\
\-\ size\\:\\ 0\\.030906487956155644\ \(0\)\
\-\ bilaterally\\:\\ 0\\.0304421905739385\ \(0\)\
\-\ air\\:\\ 0\\.02985619804671771\ \(0\)\
\-\ often\\:\\ 0\\.02978361851753655\ \(0\)\
\-\ bowel\\:\\ 0\\.02929319926360112\ \(0\)\
\-\ during\\:\\ 0\\.02891169223605882\ \(0\)\
\-\ usually\\:\\ 0\\.028735468456135137\ \(0\)\
\-\ only\\:\\ 0\\.028516654557719467\ \(0\)\
\-\ renal\\:\\ 0\\.028424678392976226\ \(0\)\
\-\ years\\:\\ 0\\.027980017433452922\ \(0\)\
\-\ neck\\:\\ 0\\.027922553357178137\ \(0\)\
\-\ pulmonary\\:\\ 0\\.027822973640720852\ \(0\)\
\-\ for\\:\\ 0\\.0276695388930678\ \(0\)\
\-\ on\\:\\ 0\\.02757138662916682\ \(0\)\
\-\ cystic\\:\\ 0\\.027490669632201883\ \(0\)\
\-\ abnormal\\:\\ 0\\.027423143170435642\ \(0\)\
\-\ the\\:\\ 0\\.027323731803141734\ \(0\)\
\-\ edema\\:\\ 0\\.027223916989982937\ \(0\)\
\-\ chronic\\:\\ 0\\.027093802932397083\ \(0\)\
\-\ time\\:\\ 0\\.02705517773318925\ \(0\)\
\-\ performed\\:\\ 0\\.02700396579369984\ \(0\)\
\-\ been\\:\\ 0\\.026593525149618595\ \(0\)\
\-\ blood\\:\\ 0\\.026509104068720927\ \(0\)\
\-\ therapy\\:\\ 0\\.02622624086480778\ \(0\)\
\-\ cell\\:\\ 0\\.02611126994683714\ \(0\)\
\-\ abdominal\\:\\ 0\\.024964678304473267\ \(0\)\
\-\ physical\\:\\ 0\\.024749981960716476\ \(0\)\
\-\ acute\\:\\ 0\\.024692414530895768\ \(0\)\
\-\ increased\\:\\ 0\\.024682860096050634\ \(0\)\
\-\ soft\\:\\ 0\\.024300637911965406\ \(0\)\
\-\ chest\\:\\ 0\\.024093953452104553\ \(0\)\
\-\ associated\\:\\ 0\\.024058547030478033\ \(0\)\
\-\ can\\:\\ 0\\.023953258166244353\ \(0\)\
\-\ woman\\:\\ 0\\.023772271880245433\ \(0\)\
\-\ most\\:\\ 0\\.02375524668609487\ \(0\)\
\-\ demonstrate\\:\\ 0\\.023729776622472266\ \(0\)\
\-\ small\\:\\ 0\\.023545432929354917\ \(0\)\
\-\ present\\:\\ 0\\.023422135601902244\ \(0\)\
\-\ lower\\:\\ 0\\.023324847616461874\ \(0\)\
\-\ demonstrates\\:\\ 0\\.022931750984210648\ \(0\)\
\-\ findings\\:\\ 0\\.02252783415172477\ \(0\)\
\-\ surgical\\:\\ 0\\.022185151782892015\ \(0\)\
\-\ female\\:\\ 0\\.02202600924447835\ \(0\)\
\-\ treatment\\:\\ 0\\.021743324502758104\ \(0\)\
\-\ an\\:\\ 0\\.017454646504639713\ \(0\)\
\-\ history\\:\\ 0\\.01743918401049083\ \(0\)\
\-\ patient\\:\\ 0\\.014846156117819115\ \(0\)\
\-\ year\\:\\ 0\\.014067012602784626\ \(0\)\
\-\ old\\:\\ 0\\.013509201515927955\ \(0\)\
